Theertha-affiliated research published in BioFactors (2024) reviews extracellular vesicles (EVs), or exosomes, as a promising therapeutic tool in heart-tissue regeneration.
EVs carry molecular cargo between cells and are being explored as cell-free regenerative therapies — potentially delivering the benefits of cell therapy without transplanting the cells themselves. This line of research underpins Theertha's exosome and extracellular-vesicle platform.
Author: Thangavelu Soundara Rajan, R&D Unit, Theertha Biopharma, Bengaluru. See our Publications & Patents and our technology platforms.